|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 1/20 | |
| C07K 14/33 |
| (11) | Patento numeris | 2909307 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13786535.8 |
| Europos patento paraiškos padavimo data | 2013-10-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2013/059183 |
| Data | 2013-10-07 |
| (87) | Numeris | WO 2014/060898 |
| Data | 2014-04-24 |
| (30) | Numeris | Data | Šalis |
| 201261716605 P | 2012-10-21 | US |
| (72) |
JANSEN, Kathrin Ute, US
ANDERSON, Annaliesa Sybil, US
DONALD, Robert G.K., US
FLINT, Michael James, US
KALYAN, Narender Kumar, US
LOTVIN, Jason Arnold, US
SIDHU, Maninder K, US
MORAN, Justin Keith, US
RUPPEN, Mark Edward, US
SUN, Weiqiang, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN |
| COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN |